Reyes Financial Architecture’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
+52,885
New +$9.09M 5.63% 4
2026
Q1
Sell
-730
Closed -$123K 391
2025
Q4
$123K Hold
730
0.08% 97
2025
Q3
$105K Buy
+730
New +$99.6K 0.07% 118
2025
Q2
Sell
-45
Closed -$5.76K 309
2025
Q1
$5.76K Hold
45
﹤0.01% 257
2024
Q4
$5.95K Buy
+45
New +$6.33K ﹤0.01% 230

Other funds holding IBB

Reyes Financial Architecture's IBB Position: Q2 2026 in Review

Reyes Financial Architecture opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 52,885 shares worth $10.1M. The stake represents 5.63% of the portfolio and ranks #4 among its holdings. This is a return to the name: Reyes Financial Architecture previously reported a position in IBB as recently as Q4 2025.

Reyes Financial Architecture first reported a position in IBB in Q4 2024 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Reyes Financial Architecture held 52,885 shares of iShares Biotechnology ETF worth $10.1M as of Q2 2026.
  • iShares Biotechnology ETF was a new Reyes Financial Architecture position in Q2 2026.
  • iShares Biotechnology ETF made up 5.63% of Reyes Financial Architecture's portfolio in Q2 2026, its #4 holding.
  • Reyes Financial Architecture first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Reyes Financial Architecture's 13F filing for Q2 2026, filed 17 Jul 2026.